Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

VirtualScopics Regains NASDAQ Compliance



                   VirtualScopics Regains NASDAQ Compliance

PR Newswire

ROCHESTER, N.Y., Sept. 6, 2013

ROCHESTER, N.Y., Sept. 6, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: 
VSCP), a leading provider of quantitative imaging, today announced that it has
received notification from The NASDAQ Stock Market that it has regained
compliance with the minimum $1.00 per share bid price requirement, and
further, that it currently complies with all other applicable standards for
continued listing.

To regain compliance with the bid price rule, the Company was required to
evidence a closing bid price of $1.00 per share or more for a period of at
least 10 consecutive trading days.  The Company effected a reverse stock split
with a ratio of 1-for-10 on August 21, 2013.  On September 5, 2013, the
closing price of the Company's common stock was $4.84 per share which marked
the tenth consecutive day the stock price had a closing bid price above $1.00
per share.  Since the Company has achieved compliance with the bid price rule,
there is no need for the Company to initiate the appeal process with NASDAQ.

VirtualScopics will continue to trade on the NASDAQ Capital Market and the
previously disclosed delisting proceeding related to its bid price compliance
is now closed.

About VirtualScopics, Inc.  
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate
drug and medical device development.  VirtualScopics has developed a robust
software platform for analysis and modeling of both structural and functional
medical images.  In combination with VirtualScopics' industry-leading
experience and expertise in advanced imaging biomarker measurement, this
platform provides a uniquely clear window into the biological activity of
drugs and devices in clinical trial patients, allowing sponsors to make better
decisions faster.  For more information about VirtualScopics, visit
www.virtualscopics.com.

Forward-Looking Statements

The statements contained in this press release that are not purely historical
are forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended and Section 21E of the Securities Exchange
Act of 1934, as amended, and are intended to be covered by the safe harbors
created thereby. These forward-looking statements include, but are not limited
to, statements regarding the company's ability to maintain compliance with
NASDAQ listing standards and/or statements preceded by, followed by or that
include the words "believes," "could," "expects," "anticipates," "estimates,"
"intends," "plans," "projects," "seeks," or similar expressions.
 Forward-looking statements deal with the company's current plans, intentions,
beliefs and expectations. Investors are cautioned that all forward-looking
statements involve risks and uncertainties that could cause actual results to
differ materially from those in the forward-looking statements. Many of these
risks and uncertainties are discussed in the company's Annual Report on Form
10-K for the fiscal year ended December 31, 2012, filed with the Securities
and Exchange Commission (the "SEC"), and in any subsequent reports filed with
the SEC, all of which are available at the SEC's website at www.sec.gov. All
forward-looking statements speak only as of the date of this press release and
the company undertakes no obligation to update such forward-looking
statements.

CONTACTS:    Company Contact:
             Jeff Markin
             President and CEO
             500 Linden Oaks
             Rochester, New York 14625
             +1 585 249.6231

SOURCE VirtualScopics, Inc.

Website: http://www.virtualscopics.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement